Literature DB >> 25646256

Incidence of dengue virus infection in school-aged children in Puerto Rico: a prospective seroepidemiologic study.

D Fermín Argüello1, Kay M Tomashek1, Luz Quiñones1, Manuela Beltran1, Luz Acosta1, Luis M Santiago1, Brad J Biggerstaff1, Enid J Garcia-Rivera1, Wellington Sun1, Laurence Pollissard-Gadroy1, Christine Luxemburger1, Elizabeth Hunsperger2.   

Abstract

Dengue is a potentially fatal acute febrile illness caused by the mosquito-borne dengue viruses (DENV-1 to -4). To estimate DENV seroincidence in school-aged children, a 1-year prospective cohort study was conducted in Patillas, Puerto Rico; 10- to 18-year-olds (N = 345) were randomly selected from 13 public schools. At enrollment, 49.8% of the entire cohort had DENV immunoglobulin G (IgG) anti-DENV antibodies, and there were individuals with neutralizing antibodies specific to each of the four DENV. The mean age of participants with incident DENV infection was 13.4 years. The 1-year seroincidence rate was 5.6%, and 61.1% of infections were inapparent. Having IgG anti-DENV at enrollment was associated with seroincidence (risk ratio = 6.8). Acute febrile illnesses during the study period were captured by a fever diary and an enhanced and passive surveillance system in the municipios of Patillas and Guayama. In summary, at enrollment, nearly one-half of the participants had a prior DENV infection, with the highest incidence in the 10- to 11-year-olds, of which most were inapparent infections, and symptomatic infections were considered mild. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25646256      PMCID: PMC4350535          DOI: 10.4269/ajtmh.14-0231

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

Review 1.  Impact of dengue/dengue hemorrhagic fever on the developing world.

Authors:  D J Gubler; M Meltzer
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis.

Authors:  M P Miagostovich; R M Nogueira; F B dos Santos; H G Schatzmayr; E S Araújo; V Vorndam
Journal:  J Clin Virol       Date:  1999-12       Impact factor: 3.168

3.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

4.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

5.  Comparison of three methods used to isolate dengue virus type 2.

Authors:  W A Chappell; C H Calisher; R F Toole; K C Maness; D R Sasso; B E Henderson
Journal:  Appl Microbiol       Date:  1971-12

6.  The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico in 1998.

Authors:  José G Rigau-Pérez; Aurimar Ayala-López; Enid J García-Rivera; Sharon M Hudson; Vance Vorndam; Paul Reiter; Marta P Cano; Gary G Clark
Journal:  Am J Trop Med Hyg       Date:  2002-10       Impact factor: 2.345

7.  A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam.

Authors:  Nguyen Thi Kim Tien; Christine Luxemburger; Nguyen Trong Toan; Laurence Pollissard-Gadroy; Vu Thi Que Huong; Pham Van Be; Nguyen Ngoc Rang; Tram-Anh Wartel; Jean Lang
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-07-13       Impact factor: 2.184

8.  Description of a large island-wide outbreak of dengue in Puerto Rico, 2007.

Authors:  Kay M Tomashek; Aidsa Rivera; Jorge L Muñoz-Jordan; Elizabeth Hunsperger; Luis Santiago; Oscar Padro; Enid Garcia; Wellington Sun
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

9.  Risk factors for dengue infection during an outbreak in Yanes, Puerto Rico in 1991.

Authors:  L Rodriguez-Figueroa; J G Rigau-Perez; E L Suarez; P Reiter
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

10.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.

Authors:  Timothy P Endy; Ananda Nisalak; Supamit Chunsuttitwat; David W Vaughn; Sharone Green; Francis A Ennis; Alan L Rothman; Daniel H Libraty
Journal:  J Infect Dis       Date:  2004-03-01       Impact factor: 5.226

View more
  14 in total

Review 1.  The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.

Authors:  Leah C Katzelnick; Eva Harris
Journal:  Curr Opin Virol       Date:  2018-03-26       Impact factor: 7.090

2.  Risk factors for infection with chikungunya and Zika viruses in southern Puerto Rico: A community-based cross-sectional seroprevalence survey.

Authors:  Laura E Adams; Liliana Sánchez-González; Dania M Rodriguez; Kyle Ryff; Chelsea Major; Olga Lorenzi; Mark Delorey; Freddy A Medina; Jorge L Muñoz-Jordán; Grayson Brown; Marianyoly Ortiz; Stephen H Waterman; Vanessa Rivera-Amill; Gabriela Paz-Bailey
Journal:  PLoS Negl Trop Dis       Date:  2022-06-13

3.  Incidence and risk factors for Dengue virus (DENV) infection in the first 2 years of life in a Brazilian prospective birth cohort.

Authors:  P M S Castanha; U R Montarroyos; S M M Silveira; G D M Albuquerque; M J G Mello; K G S Lopes; M T Cordeiro; E T A Marques; C M T Martelli; C Braga
Journal:  Epidemiol Infect       Date:  2017-09-18       Impact factor: 4.434

4.  Immune status alters the probability of apparent illness due to dengue virus infection: Evidence from a pooled analysis across multiple cohort and cluster studies.

Authors:  Hannah E Clapham; Derek A T Cummings; Michael A Johansson
Journal:  PLoS Negl Trop Dis       Date:  2017-09-27

5.  Complete Genome Sequence of Dengue virus Type 2 from a Resident of North-Central Florida with Locally Transmitted Dengue Fever.

Authors:  Sarah K White; Nicole M Iovine; L Connor Nickels; J Glenn Morris; John A Lednicky
Journal:  Genome Announc       Date:  2017-08-03

6.  Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh.

Authors:  Parnali Dhar-Chowdhury; Kishor Kumar Paul; C Emdad Haque; Shakhawat Hossain; L Robbin Lindsay; Antonia Dibernardo; W Abdullah Brooks; Michael A Drebot
Journal:  PLoS Negl Trop Dis       Date:  2017-03-23

7.  Dengue Infection in Children in Fortaleza, Brazil: A 3-Year School-Based Prospective Cohort Study.

Authors:  Ivo C B Coelho; François Haguinet; Jeová Keny B Colares; Zirlane C B Coelho; Fernanda M C Araújo; Waleska Dias Schwarcz; Ana Claudia Duarte; Beatriz Borges; Catherine Minguet; Adrienne Guignard
Journal:  Am J Trop Med Hyg       Date:  2020-04-23       Impact factor: 2.345

8.  Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia: implications for vaccine introduction.

Authors:  Mabel Carabali; Jacqueline Kyungah Lim; Diana Carolina Velez; Andrea Trujillo; Jorge Egurrola; Kang Sung Lee; Jay S Kaufman; Luiz Jacinto DaSilva; Ivan Dario Velez; Jorge E Osorio
Journal:  Int J Infect Dis       Date:  2017-03-09       Impact factor: 3.623

9.  Contributions from the silent majority dominate dengue virus transmission.

Authors:  Quirine A Ten Bosch; Hannah E Clapham; Louis Lambrechts; Veasna Duong; Philippe Buchy; Benjamin M Althouse; Alun L Lloyd; Lance A Waller; Amy C Morrison; Uriel Kitron; Gonzalo M Vazquez-Prokopec; Thomas W Scott; T Alex Perkins
Journal:  PLoS Pathog       Date:  2018-05-03       Impact factor: 6.823

Review 10.  Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review.

Authors:  Camille Fritzell; Dominique Rousset; Antoine Adde; Mirdad Kazanji; Maria D Van Kerkhove; Claude Flamand
Journal:  PLoS Negl Trop Dis       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.